[BREAKING] [Exclusive] Stock prices rise due to approval from the Celltrion Food and Drug Administration.

26 April Share

[BREAKING] [Exclusive] Stock prices rise due to approval from the Celltrion Food and Drug Administration.

[単独]コロナ治療剤「セルトリオン」食品医薬品安全処の承認により株価上昇。

[独家] 新冠病毒治疗剂Celltrion 食药处批准后股价上涨

[Основной] Повышение цены на акции в связи с одобрением препарата для лечения коронарных лекарственных средств

[단독] 코로나 치료제 셀트리온 식약처 승인으로 인해서 주가상승 [More News]